Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).
XinLei AiPengXin ZhangXinMin XieBo QiuYujia ZhuLei ZhaoMian XiYingJia WuSuPing GuoJinYu GuoFangJie LiuDaQuan WangNaiBin ChenQianWen HeYongHong HuMengZhong LiuZhaoXia DingHui LiuPublished in: Cancer medicine (2023)
Pretreatment PEG is associated with better nutritional status and treatment outcome in ESCC patients treated with CCRT compared with ONS and NTF. Pretreatment of PEG can be cost-effective because of its significant clinical benefits.